Average Co-Inventor Count = 3.98
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Ottawa (7 from 163 patents)
2. Aegera Therapeutics, Inc. (7 from 24 patents)
3. Apoptogen, Inc. (1 from 5 patents)
15 patents:
1. 7776552 - Mammalian IAP gene family, primers, probes and detection methods
2. 7235372 - Use of neuronal apoptosis inhibitor protein (NAIP)
3. 7067281 - Mammalian IAP gene family, primers, probes and detection methods
4. 6994957 - Use of neuronal apoptosis inhibitor protein (NAIP)
5. 6977158 - Mammalian IAP gene family, primers, probes, and detection methods
6. 6946544 - XAF genes and polypeptides: methods and reagents for modulating apoptosis
7. 6709866 - Methods for enhancing survival of a neuron
8. 6689562 - Mammalian IAP gene family, primers, probes and detection methods
9. 6656704 - Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10. 6541457 - Mammalian IAP gene family, primers, probes and detection methods
11. 6495339 - Method of identifying a compound that modulates XAF-mediated apoptosis
12. 6159948 - Therapeutic and drug screening methods for the treatment and prevention
13. 6156535 - Mammalian IAP gene family, primers, probes, and detection methods
14. 6107088 - XAF genes and polypeptides: methods and reagents for modulating apoptosis
15. 5919912 - Mammalian IAP antibodies and diagnostic kits